Please use this identifier to cite or link to this item:
http://hdl.handle.net/2445/183766
Title: | Initiation and Single Dispensing in Cardiovascular and Insulin Medications: Prevalence and Explanatory Factors |
Author: | Vilaplana Carnerero, Carles Aznar Lou, Ignacio Peñarrubia María, María Teresa Serrano Blanco, Antoni Fernández-Vergel, Rita Petitbò-Antúnez, Dolors Gil Girbau, Mª Montserrat March Pujol, Marian Mendive, Juan Manuel Sánchez-Viñas, Alba Carbonell-Duacastella, Cristina Rubio Valera, Maria |
Keywords: | Malalties cardiovasculars Insulina Cardiovascular diseases Insulin |
Issue Date: | 12-May-2020 |
Publisher: | MDPI |
Abstract: | : Background: Adherence problems have negative effects on health, but there is little information on the magnitude of non-initiation and single dispensing. Objective: The aim of this study was to estimate the prevalence of non-initiation and single dispensation and identify associated predictive factors for the main treatments prescribed in Primary Care (PC) for cardiovascular disease (CVD) and diabetes. Methods: Cohort study with real-world data. Patients who received a first prescription (2013-2014) for insulins, platelet aggregation inhibitors, angiotensin-converting enzyme inhibitors (ACEI) or statins in Catalan PC were included. The prevalence of non-initiation and single dispensation was calculated. Factors that explained these behaviours were explored. Results: At three months, between 5.7% (ACEI) and 9.1% (antiplatelets) of patients did not initiate their treatment and between 10.6% (statins) and 18.4% (ACEI) filled a single prescription. Body mass index, previous CVD, place of origin and having a substitute prescriber, among others, influenced the risk of non-initiation and single dispensation. Conclusions: The prevalence of non-initiation and single dispensation of CVD medications and insulin prescribed in PC in is high. Patient and health-system factors, such as place of origin and type of prescriber, should be taken into consideration when prescribing new medications for CVD and diabetes. |
Note: | Reproducció del document publicat a: https://doi.org/10.3390/ijerph17103358 |
It is part of: | International Journal of Environmental Research and Public Health, 2020, vol. 17, num. 10, p. 3358 |
URI: | http://hdl.handle.net/2445/183766 |
Related resource: | https://doi.org/10.3390/ijerph17103358 |
ISSN: | 1661-7827 |
Appears in Collections: | Articles publicats en revistes (Farmàcia, Tecnologia Farmacèutica i Fisicoquímica) Articles publicats en revistes (Medicina) |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
715708.pdf | 810.21 kB | Adobe PDF | View/Open |
This item is licensed under a Creative Commons License